Global Non-invasive Brain Trauma Monitoring Device Market

Accessibility: Skip TopNav

# Global Non-invasive Brain Trauma Monitoring Device Market Size/Share Worth USD 32.19 Billion by 2034 at a 8.13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

## [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Non-invasive Brain Trauma Monitoring Device Market size & share revenue was valued at approximately USD 14.7 Billion in 2024 and is expected to reach USD 14.98 Billion in 2025 and is expected to reach around USD 32.19 Billion by 2034, at a CAGR of 8.13% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Natus Medical Inc., Philips Healthcare, Nihon Kohden Corporation, GE Healthcare, CAS Medical Systems Inc. (Edwards Lifesciences Corporation), Advanced Brain Monitoring, Siemens AG, Medtronic Plc., Compumedics Ltd., Integra LifeSciences, Covidien PLC, Sophysa, Spiegelberg GmbH & Co. KG, Hitachi Medical Corporation, NeuroLogica Corp., NeuroWave Systems Inc., Noraxon U.S.A, RAUMEDIC AG & Others. August 21, 2025 07:30 ET | Source: Custom Market Insights Custom Market Insights1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702


Austin, TX, USA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled **“Non-invasive Brain Trauma Monitoring Device Market Size, Trends and Insights By Product Type (Monitoring Devices, Consumables), By End-User (Hospitals, Neurological Centres, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034** in its research database.

According to the latest research study, the demand of the global Non-invasive Brain Trauma Monitoring Device Market size & share was valued at approximately USD 14.7 Billion in 2024 and is expected to reach USD 14.98 Billion in 2025 and is expected to reach a value of around USD 32.19 Billion by 2034, at a compound annual growth rate (CAGR) of about 8.13% during the forecast period 2025 to 2034.

**Non-invasive Brain Trauma Monitoring Device Market Overview**

The global market for non-invasive brain trauma monitoring devices is growing quickly because more advanced diagnostic technologies are being used, which aim to reduce the need for patients to be involved in healthcare procedures. Examples of such devices include electroencephalography (EEG), near-infrared spectroscopy (NIRS), and transcranial Doppler ultrasound, which allow for noninvasive, real-time monitoring of brain activity, intracranial pressure, and other key neurologic parameters without needing surgical access. Non-invasive techniques for assessing brain function are revolutionizing neurological care by providing safer, quicker, and better diagnostic solutions, especially in emergency units, intensive care units, and neurological treatment centers. One of the key factors driving this market is the rising demand for minimally invasive healthcare procedures. The traditional invasive approach consists of placing a catheter for intracranial pressure monitoring, which carries risks of infection, bleeding, and long recovery times. Conversely, non-invasive methods offer the advantage of avoiding these associated risks, making them a painless and low-risk option for the patient. This change is part of a broader medical effort to minimize trauma and ensure prompt diagnosis. Chronic disease management has become a major focus of these healthcare devices and equipment, as they allow patients to receive timely feedback from their healthcare providers and thus allow them to manage these chronic diseases from the comfort of their homes. In addition, healthcare providers supply these devices, which improve operational efficiency, reduce hospital stay times, and lower the overall cost of healthcare. Patient education about the advantages of non-invasive monitoring and the demand for it led to notable market growth. One of the largest bottlenecks preventing such growth is the lack of trained professionals to operate these advanced devices. Many noninvasive monitoring technologies need specific expertise for appropriate use and accurate data interpretation. A lack of a properly trained workforce, especially in the developing regions, can lead to the false interpretation of results, delayed diagnoses, and poor patient outcomes. To overcome this hurdle, investment must be directed toward extensive training programs that integrate traditional learning with practical training. In addition, the integration of artificial intelligence (AI) and machine learning (ML) in this equipment can help to bridge the skills gap by reducing human error in data analysis and assisting healthcare workers in making diagnoses.

**AI and ML in Non-invasive Brain Trauma Monitoring Devices**

The implementation of AI and ML is among the most significant changes in this market. By processing large amounts of patient data in real time, AI-powered systems improve the efficiency and accuracy of neurological assessments. As machine learning algorithms learn from new data from more patients, monitoring devices become more intelligent and effective over time. Advanced automation driven by AI facilitates predictive analytics, which means that for neurological disorders, symptoms can be identified much before they even start to make any sense. It is indeed a phenomenal step forward, as it not only saves lives but also facilitates timely treatment and personalized medication.

Another significant trend impacting the market is the growing adoption of telemedicine and remote patient monitoring solutions. The advent of digital healthcare has allowed doctors to remotely monitor brain health, avoiding in-person hospital visits and making neurological care available for patients without access to in-person hospitals, especially those in rural and underserved regions. The coronavirus pandemic has increased the importance of telehealth by accelerating the transition to remote health solutions that preserve continuity of care. This novel approach presents new avenues for the integration of non-invasive brain trauma monitoring into healthcare delivery, performed by coupling such devices with telemedicine platforms to relay the data they collect to healthcare providers who can provide immediate feedback and aid to the patients, regardless of their geographical proximity to the healthcare provider.

**End-users segment**

The non-invasive brain trauma monitoring device system market is segmented across Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America holds a leading position in the non-invasive brain trauma monitoring devices market, followed by Europe and Asia-Pacific. The U.S. dominates the market owing to the presence of key market players, a high prevalence of traumatic brain injuries, and a rising trend toward patient-centric care, which eventually aids in market growth. Europe holds a second place, which can be attributed to government initiatives supporting the implementation of non-invasive healthcare solutions, increased prevalence of neurological disorders, and a rapidly aging population that requires continuous brain monitoring.

**Key Segment**

By Product Type: Monitoring Devices, Consumables
By End-User: Hospitals, Neurological Centres, Others
By Region: North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

**Key Players**

Natus Medical Inc., Philips Healthcare, Nihon Kohden Corporation, GE Healthcare, CAS Medical Systems Inc. (Edwards Lifesciences Corporation), Advanced Brain Monitoring, Siemens AG, Medtronic Plc., Compumedics Ltd., Integra LifeSciences, Covidien PLC, Sophysa Ltd., Spiegelberg GmbH & Co. KG, Hitachi Medical Corporation, NeuroLogica Corp., NeuroWave Systems Inc., Noraxon U.S.A, RAUMEDIC AG, Sense Neuro Diagnostics, BrainScope Company Inc., Others

**Report Scope**

The report contains 220+ pages and includes sections on market size, segmentation, competitive landscape, and key player profiles.

**Contact**

Joel John
CMI Consulting LLC
1333, 701 Tillery Street Unit 12,
Austin, TX, Travis, US, 78702
USA: +1 737-734-2707
India: +91 20 46022736
Email: support@custommarketinsights.com

**About Custom Market Insights**

Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI is a one-stop solution for data collection and investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics.

**Related Links**

- Non-invasive Brain Trauma Monitoring Device Market
- Non-invasive Brain Trauma Monitoring Device Market Size
- GDPR services market
- electronic brachytherapy market
- US 3d printed medical implant market
- north america geosynthetics market
- water desalination equipment market
- intravascular ultrasound devices market
- powder metallurgy market
- US small wind power market
- lead smelting and refining market
- event management software market
- scented candles market
- traffic signal controller market
- surface mining equipment market
- healthcare digital twins market
- korea cosmetic market
- US building insulation market
- diethyl ether market
- europe small wind power market

**Recommended Reading**

- December 04, 2025 09:30 ET | Source: Custom Market Insights
- December 03, 2025 08:30 ET | Source: Custom Market Insights

Global Non-invasive Brain Trauma Monitoring Device Market Size Share Worth USD 32.19 Billion by 2034 at a 8.13% CAGR

Custom Market Insights released a 220‑page research report on the global non‑invasive brain trauma monitoring device market, estimating its size at USD 14.7 billion in 2024, USD 14.98 billion in 2025, and USD 32.19 billion by 2034 with a CAGR of 8.13%. The report identifies key players such as Natus Medical Inc., Philips Healthcare, Nihon Kohden Corporation, GE Healthcare, and others, and highlights AI/ML integration, telemedicine adoption, and regional growth trends. North America leads the market, with Europe and Asia‑Pacific following.